391 filings
Page 12 of 20
6-K
SCNI
Scinai Immunotherapeutics Ltd
29 May 19
Current Report
12:00am
6-K
SCNI
Scinai Immunotherapeutics Ltd
15 May 19
Letter from BiondVax CEO regarding BiondVax’s proposed Rights Offering
7:51am
F-1/A
SCNI
Scinai Immunotherapeutics Ltd
6 May 19
Registration statement (foreign) (amended)
10:03am
6-K
SCNI
Scinai Immunotherapeutics Ltd
1 May 19
BiondVax Announces Fourth Quarter and Full Year 2018 Financial Results and Update
6:23am
6-K
SCNI
Scinai Immunotherapeutics Ltd
23 Apr 19
Notice of an Extraordinary General Meeting of Shareholders
6:18am
6-K
SCNI
Scinai Immunotherapeutics Ltd
22 Apr 19
Report of Foreign Private Issuer
10:03am
6-K
SCNI
Scinai Immunotherapeutics Ltd
8 Apr 19
Report of Foreign Private Issuer
7:00am
UPLOAD
SCNI
Scinai Immunotherapeutics Ltd
8 Apr 19
Letter from SEC
12:00am
6-K
SCNI
Scinai Immunotherapeutics Ltd
27 Mar 19
Current Report of Foreign Issuer
4:02pm
F-1
SCNI
Scinai Immunotherapeutics Ltd
25 Mar 19
Registration statement (foreign)
4:08pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
19 Feb 19
Report of Foreign Private Issuer
7:00am
SC 13G/A
Ibex Investors LLC
28 Jan 19
BiondVax Pharmaceuticals Ltd.
4:42pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
14 Nov 18
Third Quarter 2018 Financial Results
7:30am
6-K
SCNI
Scinai Immunotherapeutics Ltd
29 Oct 18
BiondVax’s Universal Flu Vaccine Phase 3 Clinical Trial Completes First Season’s Enrollment of 4,098 Participants
6:18am
6-K
SCNI
Scinai Immunotherapeutics Ltd
23 Oct 18
BiondVax receives €8M from the European Investment Bank (EIB) in support of manufacturing facility and ongoing Phase 3 clinical trial
4:02pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
17 Sep 18
Report of Foreign Private Issuer
12:00am
6-K
SCNI
Scinai Immunotherapeutics Ltd
22 Aug 18
Second Quarter 2018 Financial Results
12:00am
6-K
SCNI
Scinai Immunotherapeutics Ltd
22 Aug 18
BiondVax Moves to New Universal Flu Vaccine Manufacturing Facility
12:00am
6-K
SCNI
Scinai Immunotherapeutics Ltd
20 Aug 18
Report of Foreign Private Issuer
12:00am